Bexarotene molecule, illustration

Bexarotene molecule, illustration

C028/0182 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 14.4MB

Downloadable file size: 954.4KB

Price image Pricing

Please login to use the price calculator


Caption: Molecular model of Bexarotene (Targretin), an oral antineoplastic medicine used to treat cutaneous T cell lymphoma, lung cancer, breast cancer, and Kaposi's sarcoma. In 2012, bexarotene was found to reduce amyloid plaque and to improve mental functioning in a small group of mice induced to exhibit Alzheimer's-like symptoms. A year later, however, the results could not be reproduced. Reduction in amyloid plaques was not found, but soluble forms of beta-amyloid were reduced. Formula: C24 H28 O2; Molecular mass: 348.478 g/mol; Carbon: gray; Hydrogen: yellow; Oxygen: red.

Release details: Model release not required. Property release not required.

Keywords: antineoplastic, bexarotene, chemical, chemistry, drug, medical, medication, medicine, model, molecular, molecular model, molecule, pharmaceutical, science, targretin

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.